Clinical Trials Directory

Trials / Completed

CompletedNCT01745380

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults

A Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Placebo for Anesthetizing Maxillary Teeth in Adults

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
150 (actual)
Sponsor
St. Renatus, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy of Kovacaine Mist, and Placebo for inducing pulpal anesthesia of the maxillary teeth in adults.

Detailed description

The study will employ a multi-center, randomized, double-blind, placebo-controlled, parallel-groups design to assess the safety and efficacy of Kovacaine Mist delivered intranasally for inducing pulpal anesthesia of maxillary teeth numbers 4 to 13 (maxillary right second premolar to maxillary left second premolar) sufficient to allow completion of the Study Dental Procedure. The maxillary teeth will be categorized in two subsets, anteriors (teeth numbers 6 to 11) and premolars (teeth numbers 4, 5, 12 and 13). The intent is to treat 150 subjects at 3 study sites, 2:1 randomization within each study site, and an overall goal of 100 subjects treated with Kovacaine Mist and 50 treated with placebo. Recruitment will be from diverse dental patient populations with at least 25% of subjects over 50 years of age. Randomization will be within strata defined by age (≤50 and \>50 years).

Conditions

Interventions

TypeNameDescription
DRUGTetracaine HCl 3% and Oxymetazoline HCl 0.05%The study drug is regional anesthetic delivered intranasally on the same side as the operative tooth
DRUGPlaceboThe placebo spray was identical in appearance to and was administered in the same volume and manner as the active ingredient.

Timeline

Start date
2013-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-12-10
Last updated
2017-01-31
Results posted
2017-01-31

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01745380. Inclusion in this directory is not an endorsement.